Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colon Cancer”

2,815 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,815 results

Testing effectiveness (Phase 2)UnknownNCT00294827
What this trial is testing

Liver Transplantation and Metastatic Colo-rectal Cancer.

Who this might be right for
Colo-rectal Cancer
Oslo University Hospital 25
Testing effectiveness (Phase 2)UnknownNCT04247256
What this trial is testing

Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI

Who this might be right for
Metastatic Colorectal Cancer
Scandion Oncology A/S 35
Testing effectiveness (Phase 2)Study completedNCT01292356
What this trial is testing

Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response

Who this might be right for
Metastatic Colon Cancer
Poitiers University Hospital 28
Not applicableLooking for participantsNCT05185245
What this trial is testing

Liver Transplantation for Non-Resectable Colorectal Liver Metastasis

Who this might be right for
Liver Metastasis Colon CancerColorectal Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03654131
What this trial is testing

Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

Who this might be right for
Colorectal CarcinomaLiver Metastases
Rigshospitalet, Denmark 100
Not applicableUnknownNCT01754272
What this trial is testing

A Non-Interventional Follow-Up to the VELOUR Study - Translational Research

Who this might be right for
Metastatic Colorectal Cancer
KU Leuven 1,226
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Not applicableWithdrawnNCT01936961
What this trial is testing

Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors

Who this might be right for
Metastatic Non-Small Cell Lung CancerMetastatic Colon CancerMetastatic Triple Negative Breast Cancer
Western Regional Medical Center
Large-scale testing (Phase 3)Study completedNCT00126256
What this trial is testing

Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastasis
Gustave Roussy, Cancer Campus, Grand Paris 570
Not applicableEnded earlyNCT01098422
What this trial is testing

Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver

Who this might be right for
Colorectal NeoplasmsLiver Neoplasms
Tony Reid, M.D., Ph.D. 10
Testing effectiveness (Phase 2)Study completedNCT00630786
What this trial is testing

Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+2 more
Amgen 53
Testing effectiveness (Phase 2)Study completedNCT00625573
What this trial is testing

Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)

Who this might be right for
Colorectal Cancer
Mt. Sinai Medical Center, Miami 29
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Testing effectiveness (Phase 2)UnknownNCT01348256
What this trial is testing

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaHepatic Metastasis
Clinica Universidad de Navarra, Universidad de Navarra 58
Early research (Phase 1)UnknownNCT05213195
What this trial is testing

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Refractory Metastatic Colorectal Cancer
Zhejiang University 38
Testing effectiveness (Phase 2)Study completedNCT03647839
What this trial is testing

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Australasian Gastro-Intestinal Trials Group 90
Testing effectiveness (Phase 2)UnknownNCT03487939
What this trial is testing

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsDrug Therapy
China Medical University, China 30
Testing effectiveness (Phase 2)Study completedNCT00165568
What this trial is testing

Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm Metastasis
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT05806931
What this trial is testing

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT01326000
What this trial is testing

RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 169
Next Page